DNA made into stable nanomaterials and medical devices
DNA, the universal code of life, can be altered to make useful medical and scientific materials, according to a study from The Scripps Research Institute. Moreover, the process isn’t just a laboratory...
View ArticleYescarta, second blood cancer gene therapy, approved by FDA
A gene therapy treatment for some hard-to-treat lymphomas was approved Wednesday by the U.S. Food and Drug Administration. The approval for Yescarta is the second in two months for this kind of gene...
View ArticleViaCyte tries again with potential diabetes cure
After receiving an additional $20 million funding, San Diego’s ViaCyte is testing a new version of its stem cell-based diabetes therapy. With the funding from California’s stem cell agency, or CIRM,...
View ArticleHearing training boosts understanding in noisy settings by 25 percent
Hearing-impaired people can understand conversation significantly better in a noisy environment by playing a brain-training exercise, according to a study published Thursday. People recognized 25...
View ArticleOvarian cancer may actually arise in Fallopian tubes
A preliminary study of ovarian cancer finds that in most cases it actually arises in the Fallopian tubes. If confirmed, the study could give rise to advances in treating this difficult cancer. “We may...
View ArticleAs Alzheimer's knowledge grows, explaining risk becomes more complicated
Alzheimer’s disease used to be thought of as something you either have or you don’t. If you have it, your mind is already deteriorating, and there’s nothing you can do about it. But in recent years...
View ArticleSalk Institute scientists get $25 million for brain atlas
Stepping up their involvement in mapping the brain, scientists at the Salk Institute have been chosen to lead a $25 million project to identify cell types throughout the mammalian brain. Funded by the...
View ArticleGlyphosate levels skyrocket in older Americans
Levels of the herbicide glyphosate have soared in older Americans in 23 years, according to a study led by University of California researchers. The study wasn’t designed to detect any potential harm...
View ArticleLow effectiveness of flu vaccine explained
The notoriously low effectiveness of seasonal flu vaccines can be explained by how they’re produced in chicken eggs, according to a study led by scientists from The Scripps Research Institute....
View ArticleCancer drug fedratinib attracts $90 million for Impact Biomedicines
Less than two weeks after raising $22.5 million, San Diego cancer drug developer Impact Biomedicines has closed a deal for up to $90 million more. The investment from Oberland Capital will support the...
View ArticleNewly discovered rare disease unites parents, researchers
More than 100 people gathered in San Diego on Sunday to discuss a rare disease that wasn’t even known to exist until three years ago. Caused by mutations in a gene called DDX3X, the disease produces...
View ArticleImmune response increases heart attack deaths
Dying heart cells cause an immune response that increases heart attack fatality, according to a study in mice led by UC San Diego and Harvard University researchers. Temporarily suppressing the immune...
View ArticleBatu Biologics gets OK to start testing cancer therapy in humans
San Diego’s Batu Biologics said Monday that it has received regulatory permission to begin human testing of its cancer immunotherapy, ValloVax. The therapy is designed to inhibit the growth of new...
View ArticleMedical tourism program launches
In the heart of San Diego's biomedical community, in a tourist-friendly setting overlooking the Pacific Ocean, civic leaders officially kicked off a program to attract wealthy patients and their...
View ArticleHow a gene that usually protects against cancer becomes the disease’s aggressor
A study led by a University of California San Diego researcher has found an explanation for one of the biggest causes of cancer, mutations in a gene that normally guards against cancer. Mutations in...
View ArticleProgenity raises $125M for prenatal genetics
San Diego biotech company Progenity said Tuesday it has raised $125 million in equity and debt. Progenity said the money will help it develop products in the area of prenatal and women’s health...
View ArticleLiver cancer suppresses immune response, UCSD study finds
Chronic liver inflammation promotes cancer by suppressing the immune system, according to a study in a mouse model led by University of California San Diego researchers. The study corrects a...
View ArticleWhat can a fruit fly teach Google and other search engines?
Can a fly brain outperform Google and other search engines? A study from Salk Institute researchers suggests that in some instances, that might be the case. Data and image searches with high-powered...
View ArticleDiscovery may show earliest stage of Alzheimer's
A new way to detect Alzheimer’s disease at the earliest stages has been reported in a study led by researchers at the Sanford Burnham Prebys Medical Discovery Institute. The researchers found a...
View ArticleHeron Therapeutics wins approval of cancer drug
San Diego’s Heron Therapeutics said Thursday it has received marketing approval for a drug to prevent chemotherapy-associated nausea and vomiting. The injectable drug, Cinvanti, is the second such...
View Article
